Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome.
暂无分享,去创建一个
Takeshi Kimura | T. Kita | T. Hiwasa | Shin Watanabe | T. Inada | M. Ohno | Po-min Chen | E. Nishi | K. Ono | Katsumi Inoue | Y. Kuwabara | K. Nishi | J. Sakamoto | M. Imai | S. Matsuda | Sayaka Saijo | Yusuke Morita | T. Murai | Masaru Tanaka | Mikiko Ohno | Kiyoto Nishi | Jiro Sakamoto | Shintaro Matsuda
[1] H. Seno,et al. Nardilysin regulates inflammation, metaplasia, and tumors in murine stomach , 2017, Scientific Reports.
[2] Eric Boerwinkle,et al. Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study , 2011, Circulation.
[3] A. Prat,et al. N‐arginine dibasic convertase is a specific receptor for heparin‐binding EGF‐like growth factor that mediates cell migration , 2001, The EMBO journal.
[4] C. Heeschen,et al. Soluble CD 40 Ligand in Acute Coronary Syndromes , 2003 .
[5] Marc S. Penn,et al. Prognostic value of myeloperoxidase in patients with chest pain. , 2003, The New England journal of medicine.
[6] T. Kita,et al. Nardilysin Enhances Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth Factor through Activation of Tumor Necrosis Factor-α-converting Enzyme* , 2006, Journal of Biological Chemistry.
[7] M. Zhan,et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. , 2010, JAMA.
[8] K. Lewandrowski,et al. Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. , 2005, American journal of clinical pathology.
[9] C. Heeschen,et al. Prognostic value of placental growth factor in patients with acute chest pain. , 2004, JAMA.
[10] K. Iwaisako,et al. Nardilysin promotes hepatocellular carcinoma through activation of signal transducer and activator of transcription 3 , 2017, Cancer science.
[11] C. Heeschen,et al. Soluble CD40 ligand in acute coronary syndromes. , 2003, New England Journal of Medicine.
[12] E. Braunwald,et al. Unstable Angina: Is It Time for a Requiem? , 2013, Circulation.
[13] T. Kita,et al. Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases. , 2008, Biochemical and biophysical research communications.
[14] Takeshi Kimura,et al. Critical roles of nardilysin in the maintenance of body temperature homoeostasis , 2014, Nature Communications.
[15] H. Seno,et al. Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signalling via enhanced ectodomain shedding of TNF-α , 2012, EMBO molecular medicine.
[16] S. Blankenberg,et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. , 2011, JAMA.
[17] Takeshi Kimura,et al. Nardilysin is involved in autoimmune arthritis via the regulation of tumour necrosis factor alpha secretion , 2017, RMD Open.
[18] Jeroen J. Bax,et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2012 .
[19] H. Seno,et al. Deletion of Nardilysin Prevents the Development of Steatohepatitis and Liver Fibrotic Changes , 2014, PloS one.
[20] J. Alpert,et al. How to use high-sensitivity cardiac troponins in acute cardiac care. , 2013, European heart journal.
[21] Petr Jarolim,et al. How to Interpret Elevated Cardiac Troponin Levels , 2011, Circulation.
[22] Jeroen J. Bax,et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.
[23] H. Kiyonari,et al. Nardilysin Is Required for Maintaining Pancreatic β-Cell Function , 2016, Diabetes.
[24] 大野 美紀子. Nardilysin regulates axonal maturation and myelination in the central and peripheral nervous system , 2010 .
[25] S. Pagano,et al. Auto-antibodies as Emergent Prognostic Markers and Possible Mediators of Ischemic Cardiovascular Diseases , 2013, Clinical Reviews in Allergy & Immunology.
[26] P. Collinson,et al. Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis , 2014, European heart journal. Acute cardiovascular care.
[27] R. Takahashi,et al. Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model , 2014, Neurobiology of Aging.
[28] C. Mueller. Biomarkers and acute coronary syndromes: an update. , 2014, European heart journal.
[29] Fred S Apple,et al. Third universal definition of myocardial infarction , 2012 .
[30] J. Alpert,et al. How to use high-sensitivity cardiac troponins in acute cardiac care , 2012 .
[31] Baris Gencer,et al. 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation. , 2015, Revista espanola de cardiologia.